Use of cyclosporin-A in experimental spinal cord injury: Design of a dosing strategy to maintain therapeutic levels

Journal of Neurotrauma

Volumn 13, Issue 10, 1996, Pages 569-572

  Ibarra, Antonio ^a,b   Reyes, Julián ^a,b   Martínez, Simón ^a,b   Correa, Dolores ^b   Guízar Sahagún, Gabriel ^a   Grijalva, Israel ^a   Castañeda Hernández, Gilberto ^c   Flores Murrieta, Francisco J ^c   Franco Bourland, Rebecca ^a,d   Madrazo, Ignacio ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

cyclosporin A; dosing regimen; pharmacokinetics; spinal cord injury; spinal cord transplantation

Indexed keywords

CYCLOSPORIN A;

ANIMAL MODEL; ARTICLE; DRUG BLOOD LEVEL; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; NERVE TRANSPLANTATION; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SPINAL CORD INJURY;

EID: 10344265037     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1996.13.569     Document Type: Article

References (14)

1. LEN, A. (1911). Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocation of spinal column. J. Am. Med. Assoc. 57, 878-880.
2. ANDERSON. D.K., REIER, P.J., WIRTH, E.D., THEELE, D.P., MARECI, T., and BROWN, S.A. (1991). Delayed grafting of fetal CNS tissue into chronic compression lesions of the adult cat spinal cord. Rest Neurol. Neurosci. 2, 309-325.
3. BACH-Y-RITA, P., and ILLIS, L.S. (1993). Spinal shock: Possible role of receptor plasticity and non synaptic transmission. Paraplegia 31, 82-87.
4. RUNDIN, P., WIDNER, H., NILSSON, O., STREECKER, R., and BJORKLUND, A. (1989). Intracerebral xenografts of dopamine neurons: Role of immunosuppression and blood-brain barrier. Exp. Brain Res. 75, 195-207.
5. CHRISTIANS, U., and SEWING, K.F. (1993). Cyclosporin metabolism in transplant patients. Pharmac. Ther, 57, 291-345.
6. GARCÍA-LÓPEZ, P., PÉRMEZ-URIZAR, J., IBARRA, A., GUÍZAR-SAHAGÚN, G., FLORES-MURRIETA, F.J., GRIJALVA-OTERO, I., and CASTAÑEDA-HERNANDEZ, G. (1995). An experimental model for the study of pharmacokinetic alterations induced by spinal cord injury in rat. Pharmaceut. Sci. 1, 133-135.
7. GUÍZAR-SAHAGÚN, G., GRIJALVA, I., MADRAZO, I., FRANCO-BOURLAND, R., SALGADO-CEBALLOS, H., IBARRA, A., and LARRIVA-SAHD, J. (1994a). Neuroprotection of completely lacerated spinal cord of adult rats by homotopic and heterotopic transplantation. Rest. Neurol. Neurosci. 7, 61-70.
8. GUÍZAR-SAHAGÚN, G., GRIJALVA, I., MADRAZO, I., et al. (1994b). Development of post-traumatic cysts in the spinal cord of rats subjected to severe spinal cord contusion. Surg. Neurol. 41, 241-249.
9. IBARRA, A., KRETSCHMER, R., GUÍZAR-SAHAGÚN, G., et al. (1996). Alteration of cyclosporin-A pharmacokinetics after experimental spinal cord injury. J. Neurotrauma 13, 267-272.
10. KAHAN, B.D. (1989). Cyclosporin. N. Engl. J. Med. 321, 1725-1738.
11. MIZRACHI, Y., OHRY, A., AVIAL, A., ROZIN, R., BROOKS, E., and SCHWARTZ, M. (1983). Systemic humoral factors participating in the course of spinal cord injury. Paraplegia 22, 287-293.
12. SEGAL, J.L. (1995). Clinical pharmacology of spinal cord injury, in: Diagnosis and Management of Disorders of the Spinal Cord. R.R. Young and R.M. Woolsey (eds), W.B. Saunders: Philadelphia, PA, pp. 414-438.
13. SEGAL, J.L., and BRUNNEMAN, S.R. (1989). Clinical pharmacokinetics in patients with spinal cord injuries. Clin. Pharmacokinet. 17, 109-129.
14. WRATHALL, J.R. (1992). Spinal cord injury models. J. Neurotrauma 9 (suppl. 1), S129-S134.